Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital Mater DeiBSP:MATD3 -0.80%83 Days Sales Outstanding is 147.77 as of Mar. 2026, which is 29% above its 10-year median of 114.62. GuruFocus rates BSP:MATD3 with a GF Score™ of 83/100 and a GF Value™ of R$5.93 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 655 Healthcare Providers & Services companies, Hospital Mater Dei ranks worse than 91.3% on this metric.
The historical rank and industry rank for Hospital Mater Dei's Days Sales Outstanding or its related term are showing as below:
BSP:MATD3'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 87.79 Med: 114.62 Max: 141.83
Current: 141.83
During the past 9 years, Hospital Mater Dei's highest Days Sales Outstanding was 141.83. The lowest was 87.79. And the median was 114.62.
BSP:MATD3's Days Sales Outstanding is ranked worse than 91.3% of 655
companies
in the Healthcare Providers & Services industry
Industry Median: 47.19
vs BSP:MATD3: 141.83
Hospital Mater Dei's Days Sales Outstanding
increased
from Mar. 2025 (143.54) to Mar. 2026 (147.77).
Hospital Mater Dei (BSP:MATD3) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Hospital Mater Dei Days Sales Outstanding Related Terms
Hospital Mater Dei Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:MATD3 vs HCA, THC, DVA: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Hospital Mater Dei's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's Days Sales Outstanding falls into.
Hospital Mater Dei Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 147.77 mean?
Hospital Mater Dei (BSP:MATD3) has a Days Sales Outstanding of 147.77 as of Mar. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Hospital Mater Dei and its competitors. This is 29% above median its historical median of 114.62. Over the past decade, Hospital Mater Dei's Days Sales Outstanding has ranged from 87.79 to 141.83. According to the industry distribution chart, Hospital Mater Dei ranks #598 out of 655 companies in the Healthcare Providers & Services industry, placing it in the top 91.3%.
Is Hospital Mater Dei's Days Sales Outstanding too high?
Hospital Mater Dei's current Days Sales Outstanding of 147.77 is 29% above median its 10-year median of 114.62. Over the past 10 years, this metric has ranged from a low of 87.79 to a high of 141.83. The Healthcare Providers & Services industry median Days Sales Outstanding is 47.19. Hospital Mater Dei's value of 147.77 is 213.1% above this industry median. Based on the distribution chart, Hospital Mater Dei ranks #598 out of 655 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Hospital Mater Dei has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #598 out of 655 companies for Days Sales Outstanding. This places Hospital Mater Dei in the lower half of its industry. The industry median Days Sales Outstanding is 47.19. Hospital Mater Dei's value of 147.77 is 213.1% above this benchmark. Historically, Hospital Mater Dei's own Days Sales Outstanding has ranged from 87.79 to 141.83 over the past decade. While the company's 10-year median is 114.62 vs. the industry median of 47.19, Hospital Mater Dei has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 47.19, based on 655 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current Days Sales Outstanding of 147.77 is 213.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 47.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current Days Sales Outstanding is 147.77, which is 29% above median its own 10-year median of 114.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.93, compared to a current price of R$4.96 — trading 16.4% below its estimated fair value. The current Days Sales Outstanding is 147.77, which is 29% above median its 10-year median of 114.62 and 213.1% above the Healthcare Providers & Services industry median of 47.19. Hospital Mater Dei's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Days Sales Outstanding is 147.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.96 is trading 16.4% below its estimated GF Value™ of R$5.93.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
Days Sales Outstanding: 147.77 (29% above median its 10-year median of 114.62)
GF Value™: R$5.93 vs. price of R$4.96 (16.4% below fair value)
Industry Position: 213.1% above the Healthcare Providers & Services median (#598 of 655)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
83GF Score
Get the complete analysis for BSP:MATD3
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
